The Role of Cardiac Surgeons in Transcatheter Structural Heart Disease Interventions.

IF 4.9 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Thoracic and Cardiovascular Surgery Pub Date : 2024-10-26 DOI:10.1016/j.jtcvs.2024.10.037

Luigi Pirelli, Kendra J Grubb, Isaac George, Andrew M Goldsweig, Tamim M Nazif, Gry Dahle, Patrick O Myers, Maral Ouzounian, Wilson Y Szeto, Francesco Maisano, Arnar Geirsson, Torsten P Vahl, Susheel K Kodali, Tsuyoshi Kaneko, Gilbert H L Tang

{"title":"The Role of Cardiac Surgeons in Transcatheter Structural Heart Disease Interventions.","authors":"Luigi Pirelli, Kendra J Grubb, Isaac George, Andrew M Goldsweig, Tamim M Nazif, Gry Dahle, Patrick O Myers, Maral Ouzounian, Wilson Y Szeto, Francesco Maisano, Arnar Geirsson, Torsten P Vahl, Susheel K Kodali, Tsuyoshi Kaneko, Gilbert H L Tang","doi":"10.1016/j.jtcvs.2024.10.037","DOIUrl":null,"url":null,"abstract":"Background: With the rapid growth and evolution of transcatheter valve therapies, surgeons are foreseeing a crucial change in their practice. Their role is rapidly evolving and the concept of a structured heart valve team is becoming central in every established SHD program. The knowledge and expertise of surgeons is adapting to a novel and revolutionized field of transcatheter valve therapies, where a multidisciplinary approach is crucial for optimal outcomes and patient satisfaction. This manuscript aims to discuss the evolving role of surgeons in structural heart interventions METHODS: We depict the importance of the heart valve team and outline the challenges surgeons are facing to establish themselves as structural heart operators.Results: The switch in clinical practice surgeons are experiencing is extremely important for the future of cardiac surgery. The results of a globally conducted real-world survey shows that despite 97% of surgeons are active members of the heart team, 80% take part to TAVR procedures, and the percentage drops significantly in mitral and tricuspid interventions.Conclusions: Surgeons need to evolve, adapt and embrace this new patient-centered paradigm and broaden their skills and competences maintaining a primary role in the treatment of valvular heat pathologies.","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":null,"pages":null},"PeriodicalIF":4.9000,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic and Cardiovascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jtcvs.2024.10.037","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: With the rapid growth and evolution of transcatheter valve therapies, surgeons are foreseeing a crucial change in their practice. Their role is rapidly evolving and the concept of a structured heart valve team is becoming central in every established SHD program. The knowledge and expertise of surgeons is adapting to a novel and revolutionized field of transcatheter valve therapies, where a multidisciplinary approach is crucial for optimal outcomes and patient satisfaction. This manuscript aims to discuss the evolving role of surgeons in structural heart interventions METHODS: We depict the importance of the heart valve team and outline the challenges surgeons are facing to establish themselves as structural heart operators.

Results: The switch in clinical practice surgeons are experiencing is extremely important for the future of cardiac surgery. The results of a globally conducted real-world survey shows that despite 97% of surgeons are active members of the heart team, 80% take part to TAVR procedures, and the percentage drops significantly in mitral and tricuspid interventions.

Conclusions: Surgeons need to evolve, adapt and embrace this new patient-centered paradigm and broaden their skills and competences maintaining a primary role in the treatment of valvular heat pathologies.

查看原文本刊更多论文

心脏外科医生在经导管结构性心脏病介入治疗中的作用。

背景：随着经导管瓣膜疗法的快速发展和演变，外科医生预见到他们的工作将发生重大变化。他们的角色正在迅速演变，结构化心脏瓣膜团队的概念正在成为每一个成熟的 SHD 项目的核心。外科医生的知识和专业技能正在适应经导管瓣膜治疗这一革命性的新领域，在这一领域中，多学科方法对于获得最佳疗效和患者满意度至关重要。本手稿旨在讨论外科医生在结构性心脏介入中不断演变的角色方法：我们描绘了心脏瓣膜团队的重要性，并概述了外科医生作为结构性心脏手术医生所面临的挑战：结果：外科医生正在经历的临床实践转变对心脏外科的未来极为重要。一项全球范围内的实际调查结果显示，尽管97%的外科医生是心脏团队的积极成员，但80%的外科医生参与了TAVR手术，而在二尖瓣和三尖瓣介入手术中，这一比例明显下降：外科医生需要不断发展、适应和接受这种以患者为中心的新模式，并拓宽他们的技能和能力，在治疗瓣膜热病变中保持主要作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Thoracic and Cardiovascular Surgery 医学-呼吸系统

CiteScore

11.20

自引率

10.00%

发文量

1079

审稿时长

68 days

期刊介绍： The Journal of Thoracic and Cardiovascular Surgery presents original, peer-reviewed articles on diseases of the heart, great vessels, lungs and thorax with emphasis on surgical interventions. An official publication of The American Association for Thoracic Surgery and The Western Thoracic Surgical Association, the Journal focuses on techniques and developments in acquired cardiac surgery, congenital cardiac repair, thoracic procedures, heart and lung transplantation, mechanical circulatory support and other procedures.